Takeda Pharmaceutical Co Ltd (TAK)
13.36
+0.10
(+0.72%)
USD |
NYSE |
May 03, 16:00
13.36
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Total Return Level: 22.88 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 22.88 |
May 01, 2024 | 22.74 |
April 30, 2024 | 22.55 |
April 29, 2024 | 22.71 |
April 26, 2024 | 22.47 |
April 25, 2024 | 22.53 |
April 24, 2024 | 22.81 |
April 23, 2024 | 23.07 |
April 22, 2024 | 23.03 |
April 19, 2024 | 22.83 |
April 18, 2024 | 22.69 |
April 17, 2024 | 22.67 |
April 16, 2024 | 22.81 |
April 15, 2024 | 22.72 |
April 12, 2024 | 23.05 |
April 11, 2024 | 23.41 |
April 10, 2024 | 23.40 |
April 09, 2024 | 23.53 |
April 08, 2024 | 23.57 |
April 05, 2024 | 23.48 |
April 04, 2024 | 23.24 |
April 03, 2024 | 23.33 |
April 02, 2024 | 23.36 |
April 01, 2024 | 23.57 |
March 28, 2024 | 23.95 |
Date | Value |
---|---|
March 27, 2024 | 24.47 |
March 26, 2024 | 24.81 |
March 25, 2024 | 24.40 |
March 22, 2024 | 24.85 |
March 21, 2024 | 24.76 |
March 20, 2024 | 25.09 |
March 19, 2024 | 24.85 |
March 18, 2024 | 25.10 |
March 15, 2024 | 24.95 |
March 14, 2024 | 24.72 |
March 13, 2024 | 24.86 |
March 12, 2024 | 24.78 |
March 11, 2024 | 25.12 |
March 08, 2024 | 25.47 |
March 07, 2024 | 25.62 |
March 06, 2024 | 25.33 |
March 05, 2024 | 24.83 |
March 04, 2024 | 24.97 |
March 01, 2024 | 25.10 |
February 29, 2024 | 25.16 |
February 28, 2024 | 25.26 |
February 27, 2024 | 25.59 |
February 26, 2024 | 25.53 |
February 23, 2024 | 25.21 |
February 22, 2024 | 25.24 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
18.70
Minimum
Mar 18 2020
30.05
Maximum
Mar 22 2021
25.25
Average
25.53
Median
Total Return Level Benchmarks
Hoya Corp | 154.97 |
Astellas Pharma Inc | 12.83 |
Nxera Pharma Co Ltd | 9.304 |
PeptiDream Inc | 13.11 |
Stemcell Holdings Inc | 0.06 |